Nageswaran A, Kinghorn G R, Shen R N, Priestley C J, Kyi T T
Department of Genito-Urinary Medicine, Royal Hallamshire Hospital, Sheffield, UK.
Int J STD AIDS. 1995 Sep-Oct;6(5):336-44. doi: 10.1177/095646249500600506.
The hospital management of 108 HIV/AIDS patients cared for by the genitourinary medicine department, Sheffield, UK between 1984-93 was retrospectively studied to quantify the services utilized by these patients and to detail the management costs (1993 price) of outpatient (OP) services, inpatient (IP) care, investigational services and therapeutic provisions. The services utilized and cost are presented separately for the different clinical stages of the infection and as per patient year. Of the 108 patients, 95 (88%) were males and 13 (12%) females; most males (76.8%) acquired the infection through homosexual exposure, while 46% of females acquired it heterosexually. The mean number of OP consultation per asymptomatic, symptomatic non-AIDS and AIDS patient years were 11.6, 16.4 and 32.8 respectively; the mean number of IP episodes for each of these clinical groups were 0.15, 0.83 and 3.88 with IP stays 0.7, 3.5 and 40.6 days per patient year respectively. The annual costs of OP care (45.26 pounds per consultation), drugs and investigations were, respectively 525 pounds, 213 pounds and 153 pounds per asymptomatic patient year, 742 pounds, 2097 pounds and 224 pounds per symptomatic non-AIDS patient year and 1485 pounds, 2928 pounds and 382 pounds per AIDS patient year. The average annual OP drug cost per patient year showed little change since 1988. However, in the AIDS group, contributions from differing drug classes showed significant changes; while the contribution of antiretroviral drugs fell from 80.2% of the drug cost per AIDS patient year in 1990 to 31.3% in 1993, that from antibiotics rose from 0.3% in 1990 to 26.4% in 1993 and other antivirals from 9.4% in 1988 to 22.6% in 1993. These changes were related to lower recommended daily dosage of zidovudine and to wider prescription of antibiotics for atypical mycobacterial infections and domiciliary gancyclovir for CMV infection. The costs of annual mean IP care, IP drugs, IP investigations and IP procedures per AIDS patient year were 5926 pounds (146 pounds per IP stay), 2983 pounds, 282 pounds and 145 pounds respectively. The overall management cost of one AIDS patient year was 14,131 pounds and lifetime AIDS management cost, based on a mean survival of 17 months, a little more than 20,000 pounds. The annual management cost of an asymptomatic and symptomatic non-AIDS patient year is approximately 1/14th and 1/4th of the cost of an AIDS patient year.
对1984年至1993年间英国谢菲尔德泌尿生殖医学科护理的108例艾滋病毒/艾滋病患者的医院管理情况进行了回顾性研究,以量化这些患者所使用的服务,并详细说明门诊(OP)服务、住院(IP)护理、检查服务和治疗措施的管理成本(1993年价格)。所使用的服务和成本按感染的不同临床阶段以及每年每位患者分别列出。108例患者中,95例(88%)为男性,13例(12%)为女性;大多数男性(76.8%)通过同性恋接触感染,而46%的女性通过异性接触感染。无症状、有症状非艾滋病和艾滋病患者每年的平均门诊咨询次数分别为11.6次、16.4次和32.8次;这些临床组中每组的平均住院次数分别为0.15次、0.83次和3.88次,每位患者每年的住院天数分别为0.7天、3.5天和40.6天。门诊护理(每次咨询45.26英镑)、药物和检查的年度成本分别为:无症状患者每年525英镑、213英镑和153英镑,有症状非艾滋病患者每年742英镑、2097英镑和224英镑,艾滋病患者每年1485英镑、2928英镑和382英镑。自1988年以来,每位患者每年的平均门诊药物成本变化不大。然而,在艾滋病组中,不同药物类别的费用占比有显著变化;抗逆转录病毒药物在艾滋病患者每年药物成本中的占比从1990年的80.2%降至1993年的31.3%,抗生素的占比从1990年的0.3%升至1993年的26.4%,其他抗病毒药物的占比从1988年的9.4%升至1993年的22.6%。这些变化与齐多夫定推荐日剂量降低以及非典型分枝杆菌感染抗生素处方范围扩大和巨细胞病毒感染家庭用更昔洛韦处方增加有关。每位艾滋病患者每年的平均住院护理、住院药物、住院检查和住院手术成本分别为5926英镑(每次住院146英镑)、2983英镑、282英镑和145英镑。一名艾滋病患者一年的总体管理成本为14131英镑,基于平均存活17个月计算,一生的艾滋病管理成本略高于20000英镑。无症状和有症状非艾滋病患者每年的管理成本约为艾滋病患者每年成本的1/14和1/4。